ENGRAIL THERAPEUTICS
Engrail Therapeutics raises $157 million in funding from F-Prime Capital, othersThe proceeds of the fund raise will help to support advancement of Engrail’s pipeline for neuropsychiatric and neurodevelopmental disorders
- Load More